---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-159400"
form_type: "8-K"
ticker: "IMA"
cik: "0001835579"
company_name: "ImageneBio, Inc."
filed_at: "2025-07-15T23:59:59+00:00"
generated_at: "2026-05-18T06:31:41.758894+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Ikena stockholders approve Inmagene merger; 1:12 reverse split; combined co. to trade as IMA

## Summary
- All 7 proposals approved including merger issuance of IKNA shares >20% and reverse split.
- 1-for-12 reverse stock split to reduce outstanding shares from ~48.2M to ~4M.
- Merger and concurrent financing expected to close around end of July 2025.
- Combined company will be ImageneBio, Inc., trading on Nasdaq under ticker IMA.
- New CUSIP for post-split common stock: 45175G 207.

## SEC filing metadata
- accession: 0001193125-25-159400
- form_type: 8-K
- ticker: IMA
- cik: 0001835579
- company_name: ImageneBio, Inc.
- filed_at: 2025-07-15T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 5.02, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1835579/000119312525159400/0001193125-25-159400-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1835579/000119312525159400/d42277d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-159400
- JSON: https://secwatch.observer/filing/0001193125-25-159400.json
- Plain text: https://secwatch.observer/filing/0001193125-25-159400.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.